Perceive Pharma

Recent Finacing

Series A

Recent Raise

$15M

Perceive Pharma develops small-molecule neuroprotective therapeutics for glaucoma and other ophthalmic diseases, advancing lead candidate PBI-671 from a partnered compound library informed by genomic screening discoveries.

California, United States

Private

perceivebio.com

Highlights

Focus Areas

Pharmaceutical

Therapeutics

Recent Investors

Financials

$15M

Total Raised

1

Funding round

6

Investors

Team

Upgrade to view the team

See the team members at Perceive Pharma.